141 related articles for article (PubMed ID: 1350319)
1. Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection.
MMWR Recomm Rep; 1992 May; 41(RR-8):1-17. PubMed ID: 1350319
[TBL] [Abstract][Full Text] [Related]
2. 1997 revised guidelines for performing CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1997 Jan; 46(RR-2):1-29. PubMed ID: 9011774
[TBL] [Abstract][Full Text] [Related]
3. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1994 Mar; 43(RR-3):1-21. PubMed ID: 7908403
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for performing single-platform absolute CD4+ T-cell determinations with CD45 gating for persons infected with human immunodeficiency virus. Centers for Disease Control and Prevention.
Mandy FF; Nicholson JK; McDougal JS;
MMWR Recomm Rep; 2003 Jan; 52(RR-2):1-13. PubMed ID: 12583540
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotyping specimens from HIV-infected persons: laboratory guidelines from the Centers for Disease Control and Prevention.
Nicholson JK
Cytometry; 1994 Mar; 18(1):55-9. PubMed ID: 7915984
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance of immunophenotyping.
Bradley J
Asian Pac J Allergy Immunol; 1992 Dec; 10(2):85-7. PubMed ID: 1363953
[No Abstract] [Full Text] [Related]
7. The Immunology Quality Assessment Proficiency Testing Program for CD3⁺4⁺ and CD3⁺8⁺ lymphocyte subsets: a ten year review via longitudinal mixed effects modeling.
Bainbridge J; Wilkening CL; Rountree W; Louzao R; Wong J; Perza N; Garcia A; Denny TN
J Immunol Methods; 2014 Jul; 409():82-90. PubMed ID: 24911327
[TBL] [Abstract][Full Text] [Related]
8. Current laboratory practices in flow cytometry for the enumeration of CD 4(+) T-lymphocyte subsets.
Whitby L; Whitby A; Fletcher M; Barnett D
Cytometry B Clin Cytom; 2015; 88(5):305-11. PubMed ID: 25828263
[TBL] [Abstract][Full Text] [Related]
9. Influence of 4- and 6-color flow cytometers and acquisition/analysis softwares on the determination of lymphocyte subsets in HIV infection.
Ashman M; Sachdeva N; Davila L; Scott G; Mitchell C; Cintron L; Rathore M; Asthana D
Cytometry B Clin Cytom; 2007 Sep; 72(5):380-6. PubMed ID: 17226862
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometry for evaluation and investigation of human immunodeficiency virus infection.
Mc Closkey TW
Methods Cell Biol; 2001; 64():567-92. PubMed ID: 11070856
[No Abstract] [Full Text] [Related]
11. Availability of flow cytometric immunophenotyping of lymphocytes to hospital patients--United States, 1990.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1992 Aug; 41(33):608-10. PubMed ID: 1354327
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the impact of a CD4+ T-cell testing laboratory improvement program.
Rosner E; Siragusa M; Schalla W; Cross D; Cohn R; Hearn T
Arch Pathol Lab Med; 1998 Jun; 122(6):512-9. PubMed ID: 9625418
[TBL] [Abstract][Full Text] [Related]
13. From the Centers for Disease Control. Availability of flow cytometric immunophenotyping of lymphocytes to hospital patients--United States.
JAMA; 1992 Sep; 268(11):1395-6. PubMed ID: 1355118
[No Abstract] [Full Text] [Related]
14. Quality control in immunophenotyping: U.S. efforts to establish common methodology and their impact. American Society for Histocompatibility and Immunogenetics.
Nicholson JK
Eur J Histochem; 1994; 38 Suppl 1():7-12. PubMed ID: 8547714
[TBL] [Abstract][Full Text] [Related]
15. External quality assessment program on CD4+ T-lymphocyte counts for persons with HIV/AIDS in Thailand: history and accomplishments.
Pobkeeree V; Lerdwana S; Siangphoe U; Noulsri E; Polsrila K; Nookhai S; Pattanapanyasat K
Asian Pac J Allergy Immunol; 2009 Dec; 27(4):225-32. PubMed ID: 20232577
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte subset changes in persons infected with human immunodeficiency virus.
Hardy NM
Ann Clin Lab Sci; 1992; 22(5):286-9. PubMed ID: 1388008
[TBL] [Abstract][Full Text] [Related]
17. National external quality assessment scheme for lymphocyte immunophenotyping in Belgium.
Van Blerk M; Bernier M; Bossuyt X; Chatelain B; D'Hautcourt JL; Demanet C; Kestens L; Van Bockstaele D; Crucitti T; Libeer JC
Clin Chem Lab Med; 2003 Mar; 41(3):323-30. PubMed ID: 12705342
[TBL] [Abstract][Full Text] [Related]
18. Difficulties in precise quantitation of CD4+ T lymphocytes for clinical trials: a review.
Fei DT; Paxton H; Chen AB
Biologicals; 1993 Sep; 21(3):221-31. PubMed ID: 7906948
[TBL] [Abstract][Full Text] [Related]
19. Dried blood spot technology for CD4+ T-cell counting.
Shapiro HM; Mandy FF; Rinke de Wit TF; Sandstrom P
Lancet; 2004 Jan; 363(9403):164; author reply 164-5. PubMed ID: 14726173
[No Abstract] [Full Text] [Related]
20. Detection of viral RNA in CD4(-)CD8(-) and CD4(-)CD8(+) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques.
Huete JM; Chatis PA; Schmitz JE; Kuroda MJ; Letvin NL; Reimann KA
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):349-60. PubMed ID: 11242521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
